Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
University of California, San Francisco
University of California, San Francisco
City of Hope Medical Center
Stanford University
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Anhui Provincial Hospital
Shanghai Pudong Hospital
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Yale University
Case Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins